Vertex Pharma (VRTX): "Triple Combination" Success More Likely - Leerink

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Vertex Pharma (VRTX): "Triple Combination" Success More Likely - Leerink

Jefferies Raises Price Target on Vertex Pharma (VRTX) to $107; Reiterates Buy

July 28, 2016 9:07 AM EDT

Jefferies reiterated a Buy rating on Vertex Pharma (NASDAQ: VRTX), and raised the price target to $107.00 (from $102.00), following the company's 2Q earnings report. Orkambi sales fell slightly short of $249M estimates. Vertex continues to expect persistence and compliance rates on... More